• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.

Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders with a complex inheritance pattern. While many rare variants in synaptic proteins have been identified in patients with ASD, little is known about their effects at the synapse and their interactions with other genetic variations. Here, following the discovery of two de novo SHANK2 deletions by the Autism Genome Project, we identified a novel 421 kb de novo SHANK2 deletion in a patient with autism. We then sequenced SHANK2 in 455 patients with ASD and 431 controls and integrated these results with those reported by Berkel et al. 2010 (n = 396 patients and n = 659 controls). We observed a significant enrichment of variants affecting conserved amino acids in 29 of 851 (3.4%) patients and in 16 of 1,090 (1.5%) controls (P = 0.004, OR = 2.37, 95% CI = 1.23-4.70). In neuronal cell cultures, the variants identified in patients were associated with a reduced synaptic density at dendrites compared to the variants only detected in controls (P = 0.0013). Interestingly, the three patients with de novo SHANK2 deletions also carried inherited CNVs at 15q11-q13 previously associated with neuropsychiatric disorders. In two cases, the nicotinic receptor CHRNA7 was duplicated and in one case the synaptic translation repressor CYFIP1 was deleted. These results strengthen the role of synaptic gene dysfunction in ASD but also highlight the presence of putative modifier genes, which is in keeping with the "multiple hit model" for ASD. A better knowledge of these genetic interactions will be necessary to understand the complex inheritance pattern of ASD.

Pubmed ID: 22346768

Authors

  • Leblond CS
  • Heinrich J
  • Delorme R
  • Proepper C
  • Betancur C
  • Huguet G
  • Konyukh M
  • Chaste P
  • Ey E
  • Rastam M
  • Anckarsäter H
  • Nygren G
  • Gillberg IC
  • Melke J
  • Toro R
  • Regnault B
  • Fauchereau F
  • Mercati O
  • Lemière N
  • Skuse D
  • Poot M
  • Holt R
  • Monaco AP
  • Järvelä I
  • Kantojärvi K
  • Vanhala R
  • Curran S
  • Collier DA
  • Bolton P
  • Chiocchetti A
  • Klauck SM
  • Poustka F
  • Freitag CM
  • Waltes R
  • Kopp M
  • Duketis E
  • Bacchelli E
  • Minopoli F
  • Ruta L
  • Battaglia A
  • Mazzone L
  • Maestrini E
  • Sequeira AF
  • Oliveira B
  • Vicente A
  • Oliveira G
  • Pinto D
  • Scherer SW
  • Zelenika D
  • Delepine M
  • Lathrop M
  • Bonneau D
  • Guinchat V
  • Devillard F
  • Assouline B
  • Mouren MC
  • Leboyer M
  • Gillberg C
  • Boeckers TM
  • Bourgeron T

Journal

PLoS genetics

Publication Data

February 20, 2012

Associated Grants

  • Agency: Wellcome Trust, Id: 075491/Z/04
  • Agency: Wellcome Trust, Id: 090532
  • Agency: Canadian Institutes of Health Research, Id: 213997
  • Agency: Medical Research Council, Id: G0601030
  • Agency: Medical Research Council, Id: G9817803B

Mesh Terms

  • Adaptor Proteins, Signal Transducing
  • Adult
  • Alternative Splicing
  • Cell Line
  • Child
  • Child Development Disorders, Pervasive
  • Child, Preschool
  • Female
  • Gene Dosage
  • Gene Expression Regulation
  • Humans
  • Male
  • Nerve Tissue Proteins
  • Neurons
  • Protein Isoforms
  • RNA Splice Sites
  • Receptors, Nicotinic
  • Sequence Deletion
  • Synapses
  • Tissue Distribution
  • alpha7 Nicotinic Acetylcholine Receptor